No insider purchase over the last 90 days. The latest, by Eshelman Ventures, LLC, was filed 02 Jul 2020.
Every trade that managers of Liquidia Technologies Inc disclose to SEC (Form 4) is tracked on this page. Nothing new has been filed by managers of Liquidia Technologies Inc in twelve months, the latest record being from 27 November 2020.
Our records for Liquidia Technologies Inc go back to 2018, with 11 purchases and 13 sales on the open market in total.
Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
25 of 48 declarations
Liquidia Technologies Inc is a company focused on developing treatments for respiratory diseases. It utilizes its nanoparticle technology platform to create innovative drug formulations.